GEODE CAPITAL MANAGEMENT, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is and the CUSIP is 14757U208. A total of 21 filers reported holding CASI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$171
-99.9%
98,133
-0.2%
0.00%
Q3 2022$255,000
-22.5%
98,308
-14.7%
0.00%
Q2 2022$329,000115,1940.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FEDERATED HERMES, INC. 900,651$1,576,1390.00%
Renaissance Technologies 10,900$200.00%
ROYAL BANK OF CANADA 58$00.00%
VANGUARD GROUP INC 257,618$461,1360.00%
UBS Group AG 1,423$2,5470.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 13$230.00%
IFP Advisors, Inc 9$10.00%
OSAIC HOLDINGS, INC. 200$00.00%
DIMENSIONAL FUND ADVISORS LP 11,508$210.00%
FRANKLIN RESOURCES INC 24,546$42,9560.00%
View complete list of CASI PHARMACEUTICALS INC shareholders